It appears that the next major advance in the treatment of rheumatoid arthritis will be the oral small-molecule drugs. These drugs are even more precise than today's existing "biologic" drugs, such as Enbrel and Humira; the new small-molecule drugs will actually attack inflammatory mediators inside the cell.
- Font size
- Email This
- Bookmark
Rheumatoid Arthritis Issues
-
The Future of Rheumatoid Arthritis Treatment
Note: All clinical content on this site is physician-reviewed, except material generated by our community members.
Featuring Content From:
- Privacy Policy|
- Service Terms and Agreement|
- Contact Us|
- About Us|
- RSS Feed|
- Site Map|
- How to Use This Site
By using this service, you accept our Terms of Use. Please read them. The consumer health information on MyRACentral.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2008. The HealthCentral Network, Inc. All rights reserved.
 | We comply with the HONcode standard for trustworthy health information: verify here. |
